• About Crohn’s Disease
  • About VIVID-1
  • About Clinical Research
  • FAQS
  • US-EN
Menu
  • About Crohn’s Disease
  • About VIVID-1
  • About Clinical Research
  • FAQS
  • US-EN
See if you are eligible

Call 1-877-249-0172

Please consider this study today.

See if you are eligible

or Call 1-877-249-0172

About The Study

The VIVID-1 Study will be evaluating if an investigational drug can reduce the symptoms of Crohn’s disease. The study will consist of approximately 1,100 participants who will initially be divided up into three different groups (one receiving the investigational drug, one receiving an approved medicine for Crohn’s disease for comparison, and one receiving placebo for comparison).

  • Privacy Policy
  • Legal Notice

© Copyright 2020 Eli Lilly and Company. All rights reserved.

Your choice regarding cookies on this site
We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences. For more detailed information on the cookies we use, please check our
Privacy Policy. By continuing to access this website you are giving us consent to collect cookies.

Accept